1. Home
  2. INSM vs AFG Comparison

INSM vs AFG Comparison

Compare INSM & AFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSM
  • AFG
  • Stock Information
  • Founded
  • INSM 1988
  • AFG 1872
  • Country
  • INSM United States
  • AFG United States
  • Employees
  • INSM N/A
  • AFG N/A
  • Industry
  • INSM Biotechnology: Pharmaceutical Preparations
  • AFG Property-Casualty Insurers
  • Sector
  • INSM Health Care
  • AFG Finance
  • Exchange
  • INSM Nasdaq
  • AFG Nasdaq
  • Market Cap
  • INSM 19.1B
  • AFG 10.3B
  • IPO Year
  • INSM 2000
  • AFG N/A
  • Fundamental
  • Price
  • INSM $96.71
  • AFG $125.31
  • Analyst Decision
  • INSM Strong Buy
  • AFG Hold
  • Analyst Count
  • INSM 17
  • AFG 3
  • Target Price
  • INSM $106.80
  • AFG $139.33
  • AVG Volume (30 Days)
  • INSM 6.2M
  • AFG 528.8K
  • Earning Date
  • INSM 08-07-2025
  • AFG 08-05-2025
  • Dividend Yield
  • INSM N/A
  • AFG 2.51%
  • EPS Growth
  • INSM N/A
  • AFG N/A
  • EPS
  • INSM N/A
  • AFG 9.52
  • Revenue
  • INSM $381,030,000.00
  • AFG $7,984,000,000.00
  • Revenue This Year
  • INSM $28.03
  • AFG N/A
  • Revenue Next Year
  • INSM $120.54
  • AFG $6.40
  • P/E Ratio
  • INSM N/A
  • AFG $13.39
  • Revenue Growth
  • INSM 20.77
  • AFG 4.76
  • 52 Week Low
  • INSM $60.40
  • AFG $114.73
  • 52 Week High
  • INSM $106.83
  • AFG $150.19
  • Technical
  • Relative Strength Index (RSI)
  • INSM 61.16
  • AFG 57.44
  • Support Level
  • INSM $98.85
  • AFG $122.84
  • Resistance Level
  • INSM $106.83
  • AFG $126.86
  • Average True Range (ATR)
  • INSM 3.11
  • AFG 2.32
  • MACD
  • INSM -1.13
  • AFG 0.34
  • Stochastic Oscillator
  • INSM 18.72
  • AFG 97.32

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

About AFG American Financial Group Inc.

American Financial Group Inc is a holding company that is engaged in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. The Company operates through two segments: Property & Casualty Insurance and Other. The Property & Casualty segment includes Property & Transportation, covering buses, trucks, marine, agriculture, and commercial property; Specialty Casualty, offering excess & surplus, liability, and professional insurance; and Specialty Financial, providing risk management for lending and leasing institutions, fidelity and surety products, and trade credit insurance. The company's insurance operations are conducted through the Great American Insurance Group.

Share on Social Networks: